CSI300 Index Rebalance Preview: 21 Changes in June, Could Be 24 in December
There could be 24 changes to the CSI300 index at the December review with an estimated one-way turnover of 4.06%. 4 inclusions and 11 deletions are...
608 Views
Burning Rock Biotech IPO: Valuation Insights
Burning Rock Biotech (BNR US) is a precision oncology and early cancer detection company. It is China’s number one NGS-based cancer therapy...
484 Views
Burning Rock Biotech IPO Initiation: Burning Ambitions
Burning Rock Biotech (BNR US) is a precision oncology and early cancer detection company. It is China’s number one NGS-based cancer therapy...
455 Views
BBI Life: Scheme Doc Out, IFA Ekes Out A Fair Opinion
Back on the 20 January, BBI Life Sciences (1035 HK), the largest supplier of DNA synthesis products in the PRC, announced a privatisation Offer by...
491 Views
AOBiome Therapeutics IPO: Hope for Natural Therapeutic Treatment
AOBiome Therapeutics, a U.S. based biotech company, is planning to raise up to USD 200 million in its listing on the Hong Kong Stock Exchange. In...
1k Views